PL2989114T3 - Pochodne 2,2-difluoropropionamidowe metylu bardoksolonu, polimorficzne postacie i sposoby ich zastosowania - Google Patents

Pochodne 2,2-difluoropropionamidowe metylu bardoksolonu, polimorficzne postacie i sposoby ich zastosowania

Info

Publication number: PL2989114T3
Authority: PL; Poland
Prior art keywords: methods; polymorphic forms; bardoxolone methyl; difluoropropionamide; derivatives
Prior art date: 2013-04-24

Application number

PL14727306T

Other languages

English (en)

Inventor

Ahmad Y. Sheikh

Alessandra MATTEI

Xiu C. Wang

Original Assignee

Abbvie Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-04-24

Filing date

2014-04-24

Publication date

2018-10-31

2014-04-24 Application filed by Abbvie Inc. filed Critical Abbvie Inc.

2018-10-31 Publication of PL2989114T3 publication Critical patent/PL2989114T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)

PL14727306T 2013-04-24 2014-04-24 Pochodne 2,2-difluoropropionamidowe metylu bardoksolonu, polimorficzne postacie i sposoby ich zastosowania PL2989114T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361815502P	2013-04-24	2013-04-24
PCT/US2014/035279 WO2014176415A1 (en)	2013-04-24	2014-04-24	2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
EP14727306.4A EP2989114B1 (en)	2013-04-24	2014-04-24	2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

Publications (1)

Publication Number	Publication Date
PL2989114T3 true PL2989114T3 (pl)	2018-10-31

Family

ID=50842351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14727306T PL2989114T3 (pl)	2013-04-24	2014-04-24	Pochodne 2,2-difluoropropionamidowe metylu bardoksolonu, polimorficzne postacie i sposoby ich zastosowania

Country Status (35)

Country	Link
US (5)	US9856286B2 (pl)
EP (2)	EP2989114B1 (pl)
JP (2)	JP6409050B2 (pl)
KR (2)	KR20150144807A (pl)
CN (1)	CN105324389B (pl)
AR (1)	AR096046A1 (pl)
AU (2)	AU2014257072C1 (pl)
BR (1)	BR112015027012B1 (pl)
CA (1)	CA2909066C (pl)
CL (1)	CL2015003135A1 (pl)
CR (1)	CR20150620A (pl)
CY (1)	CY1120570T1 (pl)
DK (1)	DK2989114T3 (pl)
DO (1)	DOP2015000263A (pl)
EC (1)	ECSP23088864A (pl)
ES (1)	ES2683626T3 (pl)
HR (1)	HRP20181321T1 (pl)
HU (1)	HUE039899T2 (pl)
IL (1)	IL242183B (pl)
LT (1)	LT2989114T (pl)
MX (1)	MX372760B (pl)
MY (1)	MY182677A (pl)
PE (1)	PE20160006A1 (pl)
PH (1)	PH12015502459B1 (pl)
PL (1)	PL2989114T3 (pl)
PT (1)	PT2989114T (pl)
RS (1)	RS57571B1 (pl)
RU (2)	RU2693833C2 (pl)
SG (2)	SG10201805231WA (pl)
SI (1)	SI2989114T1 (pl)
TW (2)	TWI649330B (pl)
UA (1)	UA118348C2 (pl)
UY (2)	UY35534A (pl)
WO (1)	WO2014176415A1 (pl)
ZA (1)	ZA201507481B (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA022166B1 (ru)	2008-01-11	2015-11-30	Ритэ Фамэсутиклс, Инк.	Синтетические тритерпеноиды и их применение в лечении заболеваний
SI2276493T1 (sl)	2008-04-18	2019-04-30	Reata Pharmaceuticals, Inc.	Antioksidantni modulatorji vnetja: derivati oleanolne kisline z amino in drugimi modifikacijami pri C-17
BRPI0911105B1 (pt)	2008-04-18	2022-11-08	Reata Pharmaceuticals, Inc	Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
EP2841445B1 (en)	2012-04-27	2017-06-14	Reata Pharmaceuticals, Inc.	2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
WO2013188818A1 (en)	2012-06-15	2013-12-19	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
PL2892912T3 (pl)	2012-09-10	2019-10-31	Reata Pharmaceuticals Inc	C17-alkanodiylowe i alkenodiylowe pochodne kwasu oleanolowego i sposoby ich zastosowania
US9278912B2 (en)	2012-09-10	2016-03-08	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
AR096046A1 (es) *	2013-04-24	2015-12-02	Abbvie Inc	Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso
EP3310786B1 (en)	2015-06-16	2021-03-03	Nanophagix LLC	Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
CN106279344A (zh) *	2016-08-14	2017-01-04	吴芊葭	一种从防风中分离的天然化合物及其制备方法、医药应用
CN106309451A (zh) *	2016-08-14	2017-01-11	吴芊葭	一种头孢呋辛酯的药物组合物及其医药用途
JP6633812B2 (ja)	2016-11-08	2020-01-22	リアタファーマシューティカルズインコーポレイテッド	バルドキソロンメチルまたはその類似体を使用してアルポート症候群を処置する方法
US20190388407A1 (en)	2017-02-12	2019-12-26	Aiviva Biopharma, Inc.	Multikinase inhibitors of vegf and tfg beta and uses thereof
CN108558985B (zh) *	2018-05-19	2019-06-07	河南省科学院高新技术研究中心	白桦脂酸衍生物及其合成方法和应用
EP3810141A1 (en)	2018-06-20	2021-04-28	Reata Pharmaceuticals, Inc.	Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
KR20210044833A (ko) *	2018-08-15	2021-04-23	아이비바 바이오파마, 인크.	Vegf 및 tgf 베타의 다중 키나아제 억제제 및 이의 용도
CN112930347B (zh)	2018-08-20	2024-07-23	詹森药业有限公司	KEAP1-Nrf2蛋白-蛋白相互作用的抑制剂
WO2020190733A1 (en) *	2019-03-15	2020-09-24	University Of Rhode Island Board Of Trustees	pHLIP®-MEDIATED TARGETING OF CORTICOSTEROIDS TO DISEASED TISSUE
WO2020226201A1 (ko) *	2019-05-08	2020-11-12	경상대학교병원	피부 저색소증 예방 또는 치료용 약학적 조성물, 건강기능식품 및 화장료 조성물
CA3144603C (en)	2019-07-19	2025-10-21	Reata Pharmaceuticals Inc	C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
CR20220345A (es) *	2019-12-19	2023-01-12	Reata Pharmaceuticals Inc	Triterpenoides sintéticos con sustituyentes a base de nitrógeno en c-17 y métodos de uso de los mismos
EP4259155A1 (en) *	2020-12-11	2023-10-18	Reata Pharmaceuticals Holdings, LLC	Synthetic triterpenoids for use in therapy
TW202245795A (zh) *	2021-01-18	2022-12-01	美商瑞塔醫藥有限責任公司	合成之熊果酸衍生物及其使用方法
CN113197905B (zh) *	2021-04-23	2022-04-19	浙江大学	三萜类化合物在制备神经母细胞瘤治疗药物中的应用
CN114344308A (zh) *	2021-12-22	2022-04-15	山西医科大学第二医院	甲基巴多索隆在制备防治骨关节炎的药物中的应用
TW202340204A (zh)	2022-01-07	2023-10-16	日商中外製藥股份有限公司	具有Nrf2活化作用的含氮雜環化合物
US20240124393A1 (en) *	2022-09-21	2024-04-18	Sicor - Societa Italiana Corticosteroidi S.R.L.	Process and intermediates for preparation of omaveloxolone and salts thereof

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4395423A (en)	1978-10-10	1983-07-26	Sterling Drug Inc.	Polycyclic cyanoketones
US5443826A (en)	1988-08-02	1995-08-22	Borody; Thomas J.	Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5064823A (en)	1988-08-24	1991-11-12	Research Triangle Institute	Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
US5599795A (en)	1994-08-19	1997-02-04	Mccann; Michael	Method for treatment of idiopathic inflammatory bowel disease (IIBD)
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US6369101B1 (en)	1999-02-26	2002-04-09	Regents Of The University Of Minnesota	Therapeutic method to treat herpes virus infection
US6649654B1 (en)	1999-11-23	2003-11-18	The Regents Of The University Of California	Methods for identifying and using IKK inhibitors
US6951847B2 (en)	2000-09-29	2005-10-04	Regents Of The University Of Minnesota	Methods of treating fungal infections using lupeol
WO2002026761A1 (en)	2000-09-29	2002-04-04	Regents Of The University Of Minnesota	Triterpenes having fungicidal activity against yeast
US6689767B2 (en)	2000-09-29	2004-02-10	Regents Of The University Of Minnesota	Triterpenes having antibacterial activity
AU2002243246A1 (en)	2000-11-28	2002-06-24	Board Of Regents, The University Of Texas System	Cddo-compounds and combination therapies thereof
US7435755B2 (en)	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
EP1465615B1 (en)	2002-01-15	2012-08-01	Trustees of Dartmouth College	Tricyclic-bis-enone derivatives and methods of use thereof
ATE417857T1 (de)	2002-01-18	2009-01-15	Univ Minnesota	Quaternäre terpensalze als biologisch aktive tenside
US6974801B2 (en)	2002-05-13	2005-12-13	The Trustees Of Dartmounth College	Inhibitors and methods of use thereof
US20050208151A1 (en)	2003-10-30	2005-09-22	Entelos, Inc.	Treatment of rheumatoid arthritis with FLIP antagonists
US20060258752A1 (en)	2004-02-12	2006-11-16	Vander Jagt David L	Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
CA2614110A1 (en)	2005-07-01	2007-01-11	The Johns Hopkins University	Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
US20070232577A1 (en)	2006-03-23	2007-10-04	Advanced Life Sciences, Inc.	Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
WO2007127791A2 (en)	2006-04-25	2007-11-08	The Administrators Of The Tulane Educational Fund	New pharmacological method for treatment of neuropathic pain
WO2008016095A1 (en)	2006-08-02	2008-02-07	Santen Pharmaceutical Co., Ltd.	PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
WO2008064133A1 (en)	2006-11-17	2008-05-29	Trustees Of Dartmouth College	Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en)	2006-11-17	2008-05-29	Trustees Of Dartmouth College	Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
WO2008111497A1 (ja)	2007-03-08	2008-09-18	Santen Pharmaceutical Co., Ltd.	トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
US20080254055A1 (en)	2007-04-11	2008-10-16	John Erich Oblong	Compositions for Regulation of Hair Growth
WO2008136838A1 (en)	2007-05-04	2008-11-13	Trustees Of Dartmouth College	Novel amide derivatives of cddo and methods of use thereof
WO2009023845A2 (en)	2007-08-15	2009-02-19	The Board Of Regents Of The University Of Texas System	Combination therapy with synthetic triterpenoids and gemcitabine
US8088824B2 (en)	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester
EA022166B1 (ru)	2008-01-11	2015-11-30	Ритэ Фамэсутиклс, Инк.	Синтетические тритерпеноиды и их применение в лечении заболеваний
TW201004627A (en)	2008-04-18	2010-02-01	Reata Pharmaceuticals Inc	Antioxidant inflammation modulators: novel derivatives of oleanolic acid
SI2276493T1 (sl)	2008-04-18	2019-04-30	Reata Pharmaceuticals, Inc.	Antioksidantni modulatorji vnetja: derivati oleanolne kisline z amino in drugimi modifikacijami pri C-17
BRPI0911105B1 (pt)	2008-04-18	2022-11-08	Reata Pharmaceuticals, Inc	Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
JP5529850B2 (ja)	2008-04-18	2014-06-25	リアタファーマシューティカルズインコーポレイテッド	抗酸化炎症モジュレーター：ｃ環中に飽和を有するオレアノール酸誘導体
EA020156B1 (ru)	2008-04-18	2014-09-30	Ритэ Фамэсутикл, Инк.	Антиоксидативные модуляторы воспаления: гомологизированные по с-17 производные олеанолевой кислоты
AU2009274037B2 (en)	2008-07-22	2015-07-09	Trustees Of Dartmouth College	Monocyclic cyanoenones and methods of use thereof
US8778990B2 (en)	2008-11-04	2014-07-15	Trustees Of Dartmouth College	Betulinic acid derivatives and methods of use thereof
SMT201700527T1 (it)	2009-02-13	2018-01-11	Reata Pharmaceuticals Inc	Composizioni di dosaggio orali, a rilascio ritardato contenenti cddo-me amorfo
JP2012525415A (ja)	2009-05-01	2012-10-22	オプソテツク・コーポレイシヨン	眼科疾患を処置または予防するための方法
RS59850B1 (sr)	2010-04-12	2020-02-28	Reata Pharmaceuticals Inc	Bardoksolon metil za lečenje gojaznosti
US20130288985A1 (en)	2010-07-15	2013-10-31	The Schepens Eye Research Institute Inc.	Compositions and methods of treatment of corneal endothelium disorders
DK2651902T3 (en)	2010-12-17	2018-01-08	Reata Pharmaceuticals Inc	TRICYCLIC PYRAZOLYL AND PYRIMIDINYL ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS
ES2729405T3 (es) *	2011-03-11	2019-11-04	Reata Pharmaceuticals Inc	Derivados triterpenoides de C4-monometilo y métodos de uso de los mismos
WO2012154554A1 (en)	2011-05-06	2012-11-15	Catabasis Pharmaceuticals, Inc.	Fatty acid triterpene derivatives and their uses
EP2841445B1 (en)	2012-04-27	2017-06-14	Reata Pharmaceuticals, Inc.	2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
US8921419B2 (en)	2012-05-08	2014-12-30	Trustees Of Dartmouth College	Triterpenoids and compositions containing the same
US8981144B2 (en)	2012-05-08	2015-03-17	Trustees Of Dartmouth College	Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
WO2013169740A2 (en)	2012-05-08	2013-11-14	Trustees Of Dartmouth College	Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
WO2013188818A1 (en)	2012-06-15	2013-12-19	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
WO2014040052A2 (en)	2012-09-10	2014-03-13	Abbvie Inc.	Glycyrrhetinic acid derivatives and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US9278912B2 (en)	2012-09-10	2016-03-08	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
CN104768965B (zh)	2012-09-10	2018-05-11	里亚塔医药公司	齐墩果酸的c17-杂芳基衍生物和其使用方法
PL2892912T3 (pl)	2012-09-10	2019-10-31	Reata Pharmaceuticals Inc	C17-alkanodiylowe i alkenodiylowe pochodne kwasu oleanolowego i sposoby ich zastosowania
AR096046A1 (es)	2013-04-24	2015-12-02	Abbvie Inc	Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso
CN112870202A (zh)	2013-08-23	2021-06-01	里亚塔医药公司	使用甲基巴多索隆或其类似物治疗和预防肾病的方法
JP6530758B2 (ja)	2014-01-24	2019-06-12	リアタファーマシューティカルズ，インク	抗酸化性炎症調節剤としてのアリールおよびアリールアルキル置換されたピラゾリルおよびピリミジニル三環式エノン類
KR102686868B1 (ko)	2015-02-12	2024-07-19	리아타 파마슈티컬즈, 아이엔씨.	항산화 염증 조절제로서의 이미다졸릴 트리사이클릭 에논
ES2865163T3 (es)	2015-09-23	2021-10-15	Reata Pharmaceuticals Inc	Derivados de ácido oleanólico modificado en C4 para la inhibición de il-17 y otros usos
JP6633812B2 (ja)	2016-11-08	2020-01-22	リアタファーマシューティカルズインコーポレイテッド	バルドキソロンメチルまたはその類似体を使用してアルポート症候群を処置する方法

2014
- 2014-04-21 AR ARP140101652A patent/AR096046A1/es unknown
- 2014-04-21 UY UY0001035534A patent/UY35534A/es active IP Right Grant
- 2014-04-21 UY UY0001039092A patent/UY39092A/es not_active Application Discontinuation
- 2014-04-21 TW TW103114431A patent/TWI649330B/zh active
- 2014-04-21 TW TW107147785A patent/TW201936625A/zh unknown
- 2014-04-24 UA UAA201511559A patent/UA118348C2/uk unknown
- 2014-04-24 AU AU2014257072A patent/AU2014257072C1/en active Active
- 2014-04-24 HR HRP20181321TT patent/HRP20181321T1/hr unknown
- 2014-04-24 KR KR1020157033427A patent/KR20150144807A/ko not_active Withdrawn
- 2014-04-24 PE PE2015002271A patent/PE20160006A1/es unknown
- 2014-04-24 CN CN201480035822.1A patent/CN105324389B/zh active Active
- 2014-04-24 RU RU2015150069A patent/RU2693833C2/ru active
- 2014-04-24 EP EP14727306.4A patent/EP2989114B1/en active Active
- 2014-04-24 CA CA2909066A patent/CA2909066C/en active Active
- 2014-04-24 ES ES14727306.4T patent/ES2683626T3/es active Active
- 2014-04-24 KR KR1020217003976A patent/KR102342915B1/ko active Active
- 2014-04-24 EP EP18170879.3A patent/EP3453715A1/en not_active Withdrawn
- 2014-04-24 RU RU2019120236A patent/RU2019120236A/ru not_active Application Discontinuation
- 2014-04-24 PT PT14727306T patent/PT2989114T/pt unknown
- 2014-04-24 BR BR112015027012-3A patent/BR112015027012B1/pt active IP Right Grant
- 2014-04-24 HU HUE14727306A patent/HUE039899T2/hu unknown
- 2014-04-24 SG SG10201805231WA patent/SG10201805231WA/en unknown
- 2014-04-24 DK DK14727306.4T patent/DK2989114T3/en active
- 2014-04-24 US US14/260,532 patent/US9856286B2/en active Active
- 2014-04-24 RS RS20180945A patent/RS57571B1/sr unknown
- 2014-04-24 MX MX2015014792A patent/MX372760B/es active IP Right Grant
- 2014-04-24 WO PCT/US2014/035279 patent/WO2014176415A1/en not_active Ceased
- 2014-04-24 SG SG11201508752WA patent/SG11201508752WA/en unknown
- 2014-04-24 MY MYPI2015703682A patent/MY182677A/en unknown
- 2014-04-24 PL PL14727306T patent/PL2989114T3/pl unknown
- 2014-04-24 JP JP2016510780A patent/JP6409050B2/ja active Active
- 2014-04-24 SI SI201430835T patent/SI2989114T1/sl unknown
- 2014-04-24 LT LTEP14727306.4T patent/LT2989114T/lt unknown
2015
- 2015-10-08 ZA ZA2015/07481A patent/ZA201507481B/en unknown
- 2015-10-16 DO DO2015000263A patent/DOP2015000263A/es unknown
- 2015-10-20 IL IL24218315A patent/IL242183B/en active IP Right Grant
- 2015-10-23 CL CL2015003135A patent/CL2015003135A1/es unknown
- 2015-10-23 PH PH12015502459A patent/PH12015502459B1/en unknown
- 2015-11-20 CR CR20150620A patent/CR20150620A/es unknown
2017
- 2017-11-22 US US15/821,508 patent/US20180094020A1/en not_active Abandoned
2018
- 2018-08-10 CY CY20181100837T patent/CY1120570T1/el unknown
- 2018-09-20 JP JP2018175962A patent/JP2019023200A/ja active Pending
- 2018-11-09 US US16/186,051 patent/US11117927B2/en active Active
2019
- 2019-01-18 AU AU2019200341A patent/AU2019200341A1/en not_active Abandoned
2021
- 2021-08-06 US US17/444,594 patent/US11873320B2/en active Active
2023
- 2023-11-23 EC ECSENADI202388864A patent/ECSP23088864A/es unknown
2024
- 2024-01-12 US US18/411,501 patent/US12384815B2/en active Active

Also Published As

Publication number	Publication date
US20240228528A1 (en)	2024-07-11
AU2014257072A1 (en)	2015-10-29
CA2909066C (en)	2021-08-03
MY182677A (en)	2021-01-29
UY39092A (es)	2021-03-26
IL242183B (en)	2019-10-31
AU2014257072C1 (en)	2020-07-16
SG11201508752WA (en)	2015-11-27
CN105324389B (zh)	2018-02-06
SG10201805231WA (en)	2018-08-30
LT2989114T (lt)	2018-08-10
PH12015502459B1 (en)	2020-11-18
RU2015150069A3 (pl)	2018-03-21
HRP20181321T1 (hr)	2018-10-19
KR102342915B1 (ko)	2021-12-24
ECSP23088864A (es)	2023-12-29
AR096046A1 (es)	2015-12-02
TWI649330B (zh)	2019-02-01
TW201518314A (zh)	2015-05-16
EP3453715A1 (en)	2019-03-13
NZ749873A (en)	2020-09-25
US20220073559A1 (en)	2022-03-10
UY35534A (es)	2014-10-31
DK2989114T3 (en)	2018-08-20
KR20150144807A (ko)	2015-12-28
RU2015150069A (ru)	2017-05-29
KR20210018555A (ko)	2021-02-17
HK1221470A1 (zh)	2017-06-02
US20140323579A1 (en)	2014-10-30
CR20150620A (es)	2016-01-12
PE20160006A1 (es)	2016-02-03
ES2683626T3 (es)	2018-09-27
WO2014176415A1 (en)	2014-10-30
EP2989114B1 (en)	2018-05-23
CL2015003135A1 (es)	2016-06-10
MX2015014792A (es)	2016-03-07
US9856286B2 (en)	2018-01-02
US20180094020A1 (en)	2018-04-05
RU2693833C2 (ru)	2019-07-05
ZA201507481B (en)	2021-05-26
SI2989114T1 (sl)	2018-09-28
RS57571B1 (sr)	2018-11-30
UA118348C2 (uk)	2019-01-10
BR112015027012A2 (pt)	2017-07-25
RU2019120236A (ru)	2019-07-22
HK1222179A1 (en)	2017-06-23
CY1120570T1 (el)	2019-07-10
HUE039899T2 (hu)	2019-02-28
US11117927B2 (en)	2021-09-14
CA2909066A1 (en)	2014-10-30
PT2989114T (pt)	2018-10-10
MX372760B (es)	2020-06-29
US11873320B2 (en)	2024-01-16
US12384815B2 (en)	2025-08-12
PH12015502459A1 (en)	2016-02-22
US20200062800A1 (en)	2020-02-27
JP2019023200A (ja)	2019-02-14
AU2014257072B2 (en)	2018-10-18
BR112015027012B1 (pt)	2023-01-10
JP2016517869A (ja)	2016-06-20
TW201936625A (zh)	2019-09-16
JP6409050B2 (ja)	2018-10-17
DOP2015000263A (es)	2015-12-15
RU2019120236A3 (pl)	2019-12-04
EP2989114A1 (en)	2016-03-02
CN105324389A (zh)	2016-02-10
AU2019200341A1 (en)	2019-02-07

Publication	Publication Date	Title
IL242183B (en)	2019-10-31	2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of their use
HUS2400010I1 (hu)	2024-05-28	Bardoxolon metil 2,2-difluorpropionamid-származékai, azok polimorf formái és eljárások alkalmazásaikra
ZA201601737B (en)	2019-09-25	Processes for preparing dihydropyrimidine derivatives and intermediates thereof
IL240475B (en)	2018-03-29	Tubulin compounds, methods for their preparation and use
EP2968307A4 (en)	2017-01-04	Carboxamide derivatives and use thereof
IL252560A0 (en)	2017-07-31	Heterocyclic derivatives and their uses
IL244268A0 (en)	2016-04-21	Heterocyclic compounds and methods of use
ZA201604502B (en)	2019-07-31	Use of benzimidazole-proline derivatives
IL244214A0 (en)	2016-04-21	Thienopiperidine derivative and its use
IL246059A0 (en)	2016-07-31	Polymorphic and amphoteric forms of cortisol 17-alpha-benzoate and methods for their preparation and use
SG11201509920UA (en)	2016-01-28	Polymorphic forms of icotinib and uses thereof
GB201412023D0 (en)	2014-08-20	Method of producting derivatives of 1,3,5-triarylbenzene and truxene